ADVERTISEMENT
News
Antiarrhythmic Agent Recalled
12/06/2019
The recall includes the following products, which were distributed throughout the United States:
- amiodarone hydrochloride injection, 450 mg/9 mL (50 mg/mL), 9-mL single-dose vial (NDC 55150-181-09) from lots CAH180001 (Exp. 1/20), CAH180003 (Exp. 2/20), and CAH180011 and CAH180012 (Exp. 6/20); and
- amiodarone hydrochloride injection, 900 mg/18 mL (50 mg/mL), 18-mL multiple-dose vial (NDC 55150-182-18) from lots CAH180013 and CAH180014 (Exp. 7/20).
AuroMedics Pharma voluntarily initiated the recall November 11, 2019. The FDA designated it Class III on November 22, 2019. Under the recall classification, use of the affected drug is not likely to cause harm.
Amiodarone hydrochloride injection is a prescription antiarrhythmic used to treat heart rhythm issues.
—Jolynn Tumolo